Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-24 7:25 pm Purchase | 2025-11-17 | 13G | GRAIL, Inc. GRAL | Farallon Capital Partners, L.P. | 2,179,684 5.500% | 232,000 (+11.91%) | Filing History |
| 2025-11-13 09:46 am Purchase | 2025-10-21 | 13G | GRAIL, Inc. GRAL | Farallon Capital Partners, L.P. | 1,947,684 4.900% | 1,947,684 (New Position) | Filing History |
| 2025-11-12 12:22 pm Sale | 2025-09-30 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 3,477,227 5.100% | -2,546,000 (-42.27%) | Filing History |
| 2025-11-12 12:17 pm Purchase | 2025-09-30 | 13G | Tango Therapeutics, Inc. TNGX | Farallon Capital Partners, L.P. | 10,757,000 9.700% | 1,600,000 (+17.47%) | Filing History |
| 2025-11-12 12:15 pm Purchase | 2025-09-30 | 13G | Liquidia Corporation LQDA | Farallon Capital Partners, L.P. | 8,565,638 9.950% | 1,733,166 (+25.37%) | Filing History |
| 2025-09-08 5:36 pm Purchase | 2025-08-29 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Farallon Capital Partners, L.P. | 5,625,098 6.000% | 5,625,098 (New Position) | Filing History |
| 2025-08-15 6:56 pm Purchase | 2025-08-08 | 13G | Assembly Biosciences, Inc. ASMB | Farallon Capital Partners, L.P. | 1,140,510 7.300% | 1,140,510 (New Position) | Filing History |
| 2025-08-13 5:00 pm Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Farallon Capital Partners, L.P. | 9,157,000 8.400% | 1,975,000 (+27.50%) | Filing History |
| 2025-08-13 4:57 pm Purchase | 2025-06-30 | 13G | Beta Bionics, Inc. BBNX | Farallon Capital Partners, L.P. | 4,203,920 9.700% | 4,203,920 (New Position) | Filing History |
| 2025-08-12 4:10 pm Sale | 2025-06-30 | 13G | The New York Times Company NYT | Farallon Capital Partners, L.P. | 5,609,546 3.500% | -3,402,030 (-37.75%) | Filing History |
| 2025-08-12 4:04 pm Sale | 2025-06-30 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 12,899,701 4.900% | -3,342,295 (-20.58%) | Filing History |
| 2025-07-11 6:32 pm Purchase | 2025-07-07 | 13G | Liquidia Corporation LQDA | Farallon Capital Partners, L.P. | 6,832,472 8.000% | 6,832,472 (New Position) | Filing History |
| 2025-06-20 2:29 pm Purchase | 2025-06-13 | 13G | 23ANDME HLDG CO MEHCQ | Farallon Capital Partners, L.P. | 1,270,908 6.200% | 1,270,908 (New Position) | Filing History |
| 2025-06-13 5:25 pm Purchase | 2025-06-06 | 13G | Tango Therapeutics, Inc. TNGX | Farallon Capital Partners, L.P. | 7,182,000 6.600% | 7,182,000 (New Position) | Filing History |
| 2025-05-20 5:59 pm Sale | 2025-05-16 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 18,635,500 6.800% | -4,804,000 (-20.50%) | Filing History |
| 2025-05-15 09:24 am Purchase | 2024-12-31 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 13,262,045 7.900% | 1,931,000 (+17.04%) | Filing History |
| 2025-05-15 09:23 am Purchase | 2024-09-30 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 11,331,045 6.900% | 2,954,820 (+35.28%) | Filing History |
| 2025-05-15 09:22 am Purchase | 2024-04-12 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 8,376,225 5.100% | 1,626,021 (+24.09%) | Filing History |
| 2025-05-13 3:45 pm Purchase | 2025-03-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 9,972,980 9.990% | 1,733,857 (+21.04%) | Filing History |
| 2025-05-08 4:09 pm Purchase | 2025-03-31 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 6,023,227 8.800% | 707,000 (+13.30%) | Filing History |